Nat Methods 14 , 671672 (2017)
The article sets out three models, staying on treatment indefinitely, reducing after a goal is reached, and cycling on and off with breaks, and says evidence most strongly supports the continuous route as the most reliable long-term approach
Retatrutide (GLP3-R) is evaluated in laboratory research for: Its multi-pathway activity differentiates it from single-receptor GLP analog peptides studied in other research frameworks
And as I get comfortable in my new lifestyle, I plan to stop looking at the scale so often
Specifically, for type 2 diabetes, risk factors for pruritus were identified to be age, duration of disease, diabetic peripheral neuropathy, diabetic retinopathy, diabetic chronic kidney disease, peripheral arterial disease, and fasting plasma glucose levels (84c,d,e)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (EMPA-REG OUTCOME)